This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

OpenAI moves to narrow authors’ ‘radically changed’ infringement claims

By Mike Swift and Emma Whitford ( July 15, 2025, 22:39 GMT | Insight) -- OpenAI has moved to narrow copyright claims by the Authors Guild and prominent writers such as John Grisham, saying the plaintiffs have put forward a new, “much broader” theory of direct copyright infringement that is based on ChatGPT's outputs rather than just the use of copyrighted works to train its large language models. OpenAI said in a court filing in New York that the plaintiffs fail to provide "any meaningful description of what the outputs contain,” and therefore this alleged infringement shouldn't be considered in the case.  OpenAI told a US judge that allegations including one that ChatGPT generated a copyright-infringing sequel to legal novelist John Grisham’s “King of Torts,” peopled with the same characters that appear in other Grisham novels, are deficient and shouldn't be considered in a recently consolidated complaint.  ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login